Compare COO & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | HTHT |
|---|---|---|
| Founded | 1980 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.6B |
| IPO Year | 1994 | 2010 |
| Metric | COO | HTHT |
|---|---|---|
| Price | $71.05 | $42.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $90.18 | $56.60 |
| AVG Volume (30 Days) | ★ 3.6M | 2.4M |
| Earning Date | 05-28-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $2,532,800,000.00 | N/A |
| Revenue This Year | $6.66 | $7.18 |
| Revenue Next Year | $5.18 | $6.71 |
| P/E Ratio | $261.30 | ★ $30.34 |
| Revenue Growth | ★ 18.41 | N/A |
| 52 Week Low | $58.89 | $30.42 |
| 52 Week High | $89.83 | $56.53 |
| Indicator | COO | HTHT |
|---|---|---|
| Relative Strength Index (RSI) | 67.72 | 36.46 |
| Support Level | $67.91 | $42.07 |
| Resistance Level | $72.07 | $45.65 |
| Average True Range (ATR) | 1.84 | 1.26 |
| MACD | 0.48 | -0.07 |
| Stochastic Oscillator | 80.31 | 31.81 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.